VentriPoint Historical Income Statement

VPT Stock

CAD 0.18 0.01 5.26%

Historical analysis of VentriPoint Diagnostics income statement accounts such as Other Operating Expenses of 3.3 M, Total Operating Expenses of 3.2 M, Income Tax Expense of 3.28 or Depreciation And Amortization of 45.9 K can show how well VentriPoint Diagnostics performed in making a profits. Evaluating VentriPoint Diagnostics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of VentriPoint Diagnostics's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining VentriPoint Diagnostics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether VentriPoint Diagnostics is a good buy for the upcoming year.

Net Income Gross Profit

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VentriPoint Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About VentriPoint Income Statement Analysis

VentriPoint Diagnostics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to VentriPoint Diagnostics shareholders. The income statement also shows VentriPoint investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

VentriPoint Diagnostics Income Statement Chart

At this time, VentriPoint Diagnostics' Research Development is fairly stable compared to the past year. Selling And Marketing Expenses is likely to climb to about 1.3 M in 2025, whereas Operating Income is likely to drop (4.7 M) in 2025.

Other Operating Expenses Total Operating Expenses Income Tax Expense Research Development

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of VentriPoint Diagnostics. It is also known as VentriPoint Diagnostics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Most accounts from VentriPoint Diagnostics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into VentriPoint Diagnostics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VentriPoint Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2022	2023	2024	2025 (projected)
Depreciation And Amortization	50.9K	66.7K	76.7K	45.9K
Income Tax Expense	136.1K	3.0	3.45	3.28

Depreciation And Amortization Income Tax Expense

VentriPoint Diagnostics income statement Correlations

	Other Operating Expenses	Operating Income	Ebitda	Total Operating Expenses	Net Income	Income Tax Expense	Depreciation And Amortization	Ebit	Research Development	Income Before Tax	Total Other Income Expense Net	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Net Income From Continuing Ops	Cost Of Revenue	Net Interest Income	Reconciled Depreciation	Interest Income
Other Operating Expenses		-0.94	-0.94	1.0	-0.85	-0.43	0.65	-0.9	0.46	-0.78	0.05	-0.3	0.64	0.7	0.28	0.34	-0.68	0.0	0.54	0.45	0.54
Operating Income	-0.94		1.0	-0.94	0.89	0.49	-0.61	0.96	-0.44	0.84	-0.03	0.35	-0.58	-0.78	-0.25	-0.3	0.74	0.05	-0.6	-0.45	-0.5
Ebitda	-0.94	1.0		-0.94	0.87	0.51	-0.6	0.97	-0.46	0.83	-0.06	0.33	-0.57	-0.8	-0.25	-0.31	0.73	0.07	-0.62	-0.42	-0.5
Total Operating Expenses	1.0	-0.94	-0.94		-0.85	-0.45	0.66	-0.91	0.45	-0.78	0.05	-0.32	0.65	0.71	0.26	0.34	-0.69	-0.04	0.55	0.46	0.54
Net Income	-0.85	0.89	0.87	-0.85		0.42	-0.58	0.83	-0.17	0.97	0.41	0.4	-0.66	-0.72	-0.18	-0.17	0.89	-0.02	-0.61	-0.57	-0.61
Income Tax Expense	-0.43	0.49	0.51	-0.45	0.42		-0.53	0.64	-0.02	0.56	0.25	0.84	-0.72	-0.72	0.38	0.01	0.62	0.67	-0.63	-0.56	-0.53
Depreciation And Amortization	0.65	-0.61	-0.6	0.66	-0.58	-0.53		-0.61	0.04	-0.59	-0.14	-0.38	0.71	0.5	-0.06	0.12	-0.54	-0.28	0.2	0.81	0.65
Ebit	-0.9	0.96	0.97	-0.91	0.83	0.64	-0.61		-0.49	0.84	-0.03	0.45	-0.66	-0.82	-0.21	-0.33	0.8	0.18	-0.66	-0.43	-0.54
Research Development	0.46	-0.44	-0.46	0.45	-0.17	-0.02	0.04	-0.49		-0.16	0.56	0.07	-0.08	0.13	0.74	0.73	-0.14	0.21	-0.01	-0.4	-0.22
Income Before Tax	-0.78	0.84	0.83	-0.78	0.97	0.56	-0.59	0.84	-0.16		0.49	0.53	-0.74	-0.77	-0.11	-0.16	0.97	0.11	-0.67	-0.59	-0.65
Total Other Income Expense Net	0.05	-0.03	-0.06	0.05	0.41	0.25	-0.14	-0.03	0.56	0.49		0.47	-0.42	-0.18	0.3	0.3	0.54	0.1	-0.26	-0.48	-0.4
Interest Expense	-0.3	0.35	0.33	-0.32	0.4	0.84	-0.38	0.45	0.07	0.53	0.47		-0.68	-0.51	0.37	0.11	0.62	0.51	-0.54	-0.57	-0.42
Selling General Administrative	0.64	-0.58	-0.57	0.65	-0.66	-0.72	0.71	-0.66	-0.08	-0.74	-0.42	-0.68		0.6	-0.25	-0.01	-0.79	-0.4	0.62	0.74	0.78
Selling And Marketing Expenses	0.7	-0.78	-0.8	0.71	-0.72	-0.72	0.5	-0.82	0.13	-0.77	-0.18	-0.51	0.6		-0.16	-0.06	-0.75	-0.27	0.77	0.55	0.69
Total Revenue	0.28	-0.25	-0.25	0.26	-0.18	0.38	-0.06	-0.21	0.74	-0.11	0.3	0.37	-0.25	-0.16		0.8	-0.05	0.55	-0.27	-0.39	-0.3
Gross Profit	0.34	-0.3	-0.31	0.34	-0.17	0.01	0.12	-0.33	0.73	-0.16	0.3	0.11	-0.01	-0.06	0.8		-0.15	-0.05	-0.29	-0.27	-0.35
Net Income From Continuing Ops	-0.68	0.74	0.73	-0.69	0.89	0.62	-0.54	0.8	-0.14	0.97	0.54	0.62	-0.79	-0.75	-0.05	-0.15		0.2	-0.67	-0.57	-0.66
Cost Of Revenue	0.0	0.05	0.07	-0.04	-0.02	0.67	-0.28	0.18	0.21	0.11	0.1	0.51	-0.4	-0.27	0.55	-0.05	0.2		-0.09	-0.31	-0.04
Net Interest Income	0.54	-0.6	-0.62	0.55	-0.61	-0.63	0.2	-0.66	-0.01	-0.67	-0.26	-0.54	0.62	0.77	-0.27	-0.29	-0.67	-0.09		0.38	0.66
Reconciled Depreciation	0.45	-0.45	-0.42	0.46	-0.57	-0.56	0.81	-0.43	-0.4	-0.59	-0.48	-0.57	0.74	0.55	-0.39	-0.27	-0.57	-0.31	0.38		0.75
Interest Income	0.54	-0.5	-0.5	0.54	-0.61	-0.53	0.65	-0.54	-0.22	-0.65	-0.4	-0.42	0.78	0.69	-0.3	-0.35	-0.66	-0.04	0.66	0.75

Click cells to compare fundamentals

VentriPoint Diagnostics Account Relationship Matchups

VentriPoint Diagnostics income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Other Operating Expenses	1.9M	3.7M	5.0M	5.0M	5.7M	3.3M
Operating Income	(1.9M)	(3.7M)	(4.9M)	(4.9M)	(4.4M)	(4.7M)
Ebitda	(1.6M)	(3.5M)	(4.7M)	(4.9M)	(4.4M)	(4.6M)
Total Operating Expenses	1.9M	3.7M	5.0M	4.9M	5.6M	3.2M
Net Income	(1.9M)	(3.9M)	(4.9M)	(4.9M)	(4.4M)	(4.2M)
Income Tax Expense	463.5K	92.9K	136.1K	3.0	3.45	3.28
Depreciation And Amortization	54.9K	48.8K	50.9K	66.7K	76.7K	45.9K
Ebit	(1.6M)	(3.6M)	(4.8M)	(4.9M)	(4.4M)	(4.7M)
Research Development	272.0K	457.3K	1.1M	1.1M	975.3K	996.3K
Income Before Tax	(1.9M)	(3.9M)	(4.9M)	(4.9M)	(4.4M)	(4.6M)
Total Other Income Expense Net	258.2K	(197.6K)	47.9K	58.6K	52.7K	50.1K
Interest Expense	229.3K	13.0K	28.2K	58.4K	52.6K	50.0K
Selling General Administrative	1.5M	2.7M	3.1M	2.8M	3.2M	1.7M
Selling And Marketing Expenses	116.8K	542.0K	810.6K	1.1M	1.2M	1.3M
Gross Profit	26.3K	(48.8K)	57.8K	(24.2K)	(21.8K)	(20.7K)
Net Income From Continuing Ops	(1.9M)	(3.9M)	(4.9M)	(4.9M)	(4.4M)	(4.6M)
Cost Of Revenue	9.7K	48.8K	10.4K	73.4K	66.1K	51.8K
Net Interest Income	(219.7K)	32.0K	(10.0K)	10.1K	11.6K	12.2K
Reconciled Depreciation	54.9K	48.8K	50.9K	66.7K	76.7K	50.7K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for VentriPoint Stock Analysis

When running VentriPoint Diagnostics' price analysis, check to measure VentriPoint Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VentriPoint Diagnostics is operating at the current time. Most of VentriPoint Diagnostics' value examination focuses on studying past and present price action to predict the probability of VentriPoint Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VentriPoint Diagnostics' price. Additionally, you may evaluate how the addition of VentriPoint Diagnostics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

VentriPoint Historical Income Statement

About VentriPoint Income Statement Analysis

VentriPoint Diagnostics Income Statement Chart

Other Operating Expenses

Total Operating Expenses

VentriPoint Diagnostics income statement Correlations

VentriPoint Diagnostics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

VentriPoint Diagnostics income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for VentriPoint Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Operating Expenses	+ 1.0	Other Operating Expenses
Ebitda	+ 1.0	Operating Income
Ebit	+ 0.97	Ebitda
Income Before Tax	+ 0.97	Net Income
Net Income From Continuing Ops	+ 0.97	Income Before Tax
Ebit	+ 0.96	Operating Income

Total Operating Expenses	- 0.94	Ebitda
Total Operating Expenses	- 0.94	Operating Income
Ebitda	- 0.94	Other Operating Expenses
Operating Income	- 0.94	Other Operating Expenses
Ebit	- 0.91	Total Operating Expenses
Ebit	- 0.9	Other Operating Expenses